Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
Quick Stats
Apr 02, 202665.8
AI Score
BUY1.04
Volume Ratio
May 12, 2026
Next Earnings
16
+ve Days (30d)
14
-ve Days (30d)
ERAS Stock Summary
Last updated Apr 02, 2026
ERAS is currently trading at $17.81, positioned above its 200-day moving average of $5.25, indicating a long-term uptrend. The stock has a 52-week range of $1.01 to $18.18.
Technical Analysis: The 50-day moving average stands at $13.32, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 71.214, suggesting the stock is in overbought territory (bullish but caution advised).
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.135, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates ERAS at 65.8/100 with a BUY recommendation.
ERAS (Erasca, Inc. Common Stock) Indicators
Last updated Apr 02, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 71.214 |
| CMF (20) | -0.135 |
| ROC (10) | 16.71 |
| ADX (14) | 42.953 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.962 |
| AROONOSC (14) | 85.714 |
| WILLAMS %R (14) | -7.021 |
| MFI (14) | 61.219 |
ERAS Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
ERAS Price vs Max Options Open Interest
ERAS Max Change In Options Open Interest
ERAS Options - Sort by Max open Interest (near term)
3rd April 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ERAS Daily Out of Money Options - Sort by Max open Interest (near term)
3rd April 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ERAS Daily In the Money Options - Sort by Max open Interest (near term)
3rd April 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ERAS Most Active Options by Volume(near term)
3rd April 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Erasca, Inc. Common Stock is above both 50 Day and 200 Day SMA which is considered Bullish.
ERAS Moving Averages Analysis
Erasca, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Apr 02, 2026
Erasca, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Apr 02, 2026
ERAS (Erasca, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Apr 02, 2026
| Days | MA |
|---|---|
| 10 | 15.52 |
| 20 | 15.07 |
| 30 | 14.69 |
| 50 | 13.32 |
| 100 | 8.71 |
| 200 | 5.25 |
ERAS Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 5.2 billion |
| Earnings/Share ($) | -0.44 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.5677 |
| EPS Estimate Next Year ($) | -0.5415 |
| WallStreet Target Price ($) | 16.8 |
| Most Recent Quarter |